Meet the Scientist Webinar: "Research Discoveries in Schizophrenia" with Daniel R. Weinberger, M.D.

It is estimated that 1 in 4 adults experiences mental illness (source: Centers for Disease Control). Current topics of interest to those affected by mental illness, their friends and families and the public are explored in this free series of “Meet the Scientist” webinars on the second Tuesday of each month. The series hosted by Dr. Jeffrey Borenstein, acting Pres. & CEO, Brain & Behavior Research Foundation, features interviews with leading mental health researchers about new technologies, diagnostic tools, early intervention strategies and next generation therapies for mental illness.

This month’s webinar features Dr. Daniel Weinberger, Dir. & CEO, Lieber Institute for Brain Development and Prof., Psychiatry, Neurology, Neuroscience, & Human Genetics, Johns Hopkins Univ. Medical School on the topic "Research Discoveries in Schizophrenia." Dr. Weinberger's research has focused on brain mechanisms involved in the pathogenesis and treatment of neuropsychiatric disorders, especially schizophrenia. He was instrumental in focusing research on the role of abnormal brain development as a risk factor for schizophrenia. His lab identified the first genetic effects that account for variation in specific human cognitive functions and in human temperament and identified brain mechanisms related to a number of genes that have been implicated in causing psychosis, including COMT, GRM3, KCNH2, DISC1, NRG1 and ERBB4. He and his colleagues developed the first high fidelity animal model of schizophrenia. In 2003, Science magazine highlighted the genetic research of his lab as the second biggest scientific breakthrough of the year, second to the origins of the cosmos. Dr. Weinberger was formerly Director of the Genes, Cognition, and Psychosis Program of the Intramural Research Program at the National Institute of Mental Health.


Register for free at


Tuesday, March 12, 2013
2:00 PM - 3:00 PM